PHARMA MAR SA Price to Sales Ratio 2019-2019 | PHMMF

Historical PS ratio values for PHARMA MAR SA (PHMMF) over the last 10 years. The current P/S ratio for PHARMA MAR SA as of July 15, 2020 is .
PHARMA MAR SA P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
0.00 nan
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $2.445B $0.192B
Pharma Mar SA is a biopharmaceutical company. It engaged in the discovery and development of marine-derived anticancer drugs. The company's product pipeline consists of PM1183, plitidepsin, and PM184 which are in clinical trial stage. It operates primarily in Germany, Italy, France, Switzerland, United Kingdom, Belgium and the United States. Pharma Mar SA is headquartered in Madrid, Spain.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $149.009B 16.41
Bristol Myers Squibb (BMY) United States $134.110B 11.20
Gilead Sciences (GILD) United States $96.148B 12.46
CSL (CSLLY) Australia $91.686B 0.00
Vertex Pharmaceuticals (VRTX) United States $76.515B 52.60
Regeneron Pharmaceuticals (REGN) United States $69.613B 26.83
Illumina (ILMN) United States $56.203B 57.75
Biogen (BIIB) United States $46.176B 7.90
Seattle Genetics (SGEN) United States $30.793B 0.00
Moderna (MRNA) United States $29.780B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $24.673B 0.00
Alexion Pharmaceuticals (ALXN) United States $24.541B 10.54
Genmab (GMAB) Denmark $23.520B 19.37
BioMarin Pharmaceutical (BMRN) United States $22.919B 207.77
Incyte (INCY) United States $22.661B 0.00
Genmab (GNMSF) Denmark $21.998B 65.31
BeiGene (BGNE) Cayman Islands $18.688B 0.00
Alnylam Pharmaceuticals (ALNY) United States $18.229B 0.00
BioNTech SE (BNTX) Germany $17.648B 0.00
Bio-Rad Laboratories (BIO.B) United States $14.723B 67.02
Exact Sciences (EXAS) United States $14.369B 0.00
Sarepta Therapeutics (SRPT) United States $13.232B 0.00
Galapagos (GLPG) Belgium $13.098B 38.53
ARGENX SE-ADR (ARGX) Netherlands $12.095B 0.00
Horizon Therapeutics Public (HZNP) Ireland $10.859B 26.72
QIAGEN (QGEN) Netherlands $10.545B 30.66
Bio-Techne Corp (TECH) United States $10.485B 69.27
Immunomedics (IMMU) United States $9.504B 0.00
ACADIA Pharmaceuticals (ACAD) United States $8.593B 0.00
Guardant Health (GH) United States $7.871B 0.00
Exelixis (EXEL) United States $7.473B 26.20
SWEDISH ORP BIO (BIOVF) Sweden $6.929B 17.24
Repligen (RGEN) United States $6.850B 120.16
Ascendis Pharma (ASND) Denmark $6.712B 0.00
Novavax (NVAX) United States $6.442B 0.00
Vir Biotechnology (VIR) United States $5.974B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.782B 124.43
Adaptive Biotechnologies (ADPT) United States $5.590B 0.00
Mirati Therapeutics (MRTX) United States $5.381B 0.00
Acceleron Pharma (XLRN) United States $5.339B 0.00
Emergent Biosolutions (EBS) United States $5.146B 33.73
Reata Pharmaceuticals (RETA) United States $5.116B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.095B 0.00
Zai Lab (ZLAB) China $4.995B 0.00
MorphoSys AG (MOR) Germany $4.528B 35.12
Global Blood Therapeutics (GBT) United States $4.449B 0.00
MyoKardia (MYOK) United States $4.402B 0.00
Blueprint Medicines (BPMC) United States $4.341B 0.00
China Biologic Products (CBPO) China $4.231B 23.52
Momenta Pharmaceuticals (MNTA) United States $4.169B 0.00
Amicus Therapeutics (FOLD) United States $4.056B 0.00
Halozyme Therapeutics (HALO) United States $3.943B 0.00
Inovio Pharmaceuticals (INO) United States $3.875B 0.00
NeoGenomics (NEO) United States $3.846B 280.85
Bluebird Bio (BLUE) United States $3.668B 0.00
Arena Pharmaceuticals (ARNA) United States $3.398B 0.00
Alkermes (ALKS) Ireland $3.021B 59.47
Deciphera Pharmaceuticals (DCPH) United States $2.983B 0.00
Denali Therapeutics (DNLI) United States $2.853B 0.00
Insmed (INSM) United States $2.769B 0.00
Fate Therapeutics (FATE) United States $2.709B 0.00
Amarin (AMRN) Ireland $2.644B 0.00
Principia Biopharma (PRNB) United States $2.450B 0.00
Twist Bioscience (TWST) United States $2.280B 0.00
Viela Bio (VIE) United States $2.143B 0.00
UniQure (QURE) Netherlands $1.990B 0.00
Ligand Pharmaceuticals (LGND) United States $1.906B 74.23
Eidos Therapeutics (EIDX) United States $1.898B 0.00
I-Mab (IMAB) China $1.862B 0.00
Editas Medicine (EDIT) United States $1.802B 0.00
Alector (ALEC) United States $1.802B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.735B 0.00
Cytokineticsorporated (CYTK) United States $1.722B 0.00
Intra-Cellular Therapies (ITCI) United States $1.594B 0.00
Sangamo Therapeutics (SGMO) United States $1.581B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.536B 0.00
Mersana Therapeutics (MRSN) United States $1.513B 0.00
Epizyme (EPZM) United States $1.504B 0.00
REGENXBIO (RGNX) United States $1.499B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.473B 0.00
Adverum Biotechnologies (ADVM) United States $1.452B 0.00
Revance Therapeutics (RVNC) United States $1.442B 0.00
Zealand Pharma (ZEAL) Denmark $1.404B 0.00
Zymeworks (ZYME) Canada $1.399B 0.00
Mesoblast (MESO) Australia $1.389B 0.00
Arvinas (ARVN) United States $1.386B 0.00
Sorrento Therapeutics (SRNE) United States $1.380B 0.00
NantKwest (NK) United States $1.356B 0.00
Coherus BioSciences (CHRS) United States $1.313B 9.17
Akcea Therapeutics (AKCA) United States $1.301B 0.00
NGM Biopharmaceuticals (NGM) United States $1.288B 0.00
Beam Therapeutics (BEAM) United States $1.257B 0.00
Zealand Pharma (ZLDPF) Denmark $1.232B 0.00
Intellia Therapeutics (NTLA) United States $1.162B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.137B 0.00
VBI Vaccines (VBIV) United States $1.121B 0.00
Arcus Biosciences (RCUS) United States $1.109B 0.00
Alcobra (ARCT) United States $1.074B 0.00
Compugen (CGEN) Israel $1.062B 0.00
Athenex (ATNX) United States $1.028B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.960B 41.25
Nabriva Therapeutics AG (NBRV) Ireland $0.951B 0.00
Retrophin (RTRX) United States $0.904B 0.00
Heska (HSKA) United States $0.899B 0.00
Myriad Genetics (MYGN) United States $0.883B 45.58
Dynavax Technologies (DVAX) United States $0.863B 0.00
Pharming Group (PHGUF) Netherlands $0.845B 22.50
Cara Therapeutics (CARA) United States $0.839B 0.00
Morphic Holding (MORF) United States $0.787B 0.00
Intrexon (PGEN) United States $0.778B 0.00
Castle Biosciences (CSTL) United States $0.777B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.765B 0.00
Cellectis S.A (CLLS) France $0.755B 0.00
Vericel (VCEL) United States $0.750B 138.50
Codexis (CDXS) United States $0.745B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.731B 0.00
Frequency Therapeutics (FREQ) United States $0.702B 0.00
Kadmon Holdings (KDMN) United States $0.698B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.656B 5.62
Sinovac Biotech (SVA) China $0.640B 20.87
Cue Biopharma (CUE) United States $0.627B 0.00
Agenus (AGEN) United States $0.618B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.606B 0.00
Kala Pharmaceuticals (KALA) United States $0.604B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.599B 0.00
AnaptysBio (ANAB) United States $0.596B 0.00
MiMedx (MDXG) United States $0.590B 0.00
Athersys (ATHX) United States $0.564B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.550B 0.00
Syros Pharmaceuticals (SYRS) United States $0.549B 0.00
Anika Therapeutics (ANIK) United States $0.537B 17.26
Syndax Pharmaceuticals (SNDX) United States $0.534B 0.00
DBV Technologies S.A (DBVT) France $0.524B 0.00
Cel-Sci (CVM) United States $0.520B 0.00
UROGEN PHARMA (URGN) United States $0.509B 0.00
Clovis Oncology (CLVS) United States $0.497B 0.00
Prothena (PRTA) Ireland $0.495B 0.00
AC Immune SA (ACIU) Switzerland $0.486B 0.00
MeiraGTx Holdings (MGTX) United States $0.469B 0.00
Protagonist Therapeutics (PTGX) United States $0.465B 0.00
BioDelivery Sciences (BDSI) United States $0.452B 23.74
Aquinox Pharmaceuticals (NLTX) United States $0.451B 0.00
Precision BioSciences (DTIL) United States $0.431B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.430B 0.00
Scholar Rock Holding (SRRK) United States $0.421B 0.00
Avid Bioservices (CDMO) United States $0.415B 0.00
Geron (GERN) United States $0.415B 0.00
Merus (MRUS) Netherlands $0.410B 0.00
CytomX Therapeutics (CTMX) United States $0.406B 0.00
IBio (IBIO) United States $0.394B 0.00
Kamada (KMDA) Israel $0.391B 16.26
Puma Biotechnology (PBYI) United States $0.389B 0.00
ANI Pharmaceuticals (ANIP) United States $0.365B 7.09
Aeglea BioTherapeutics (AGLE) United States $0.363B 0.00
WAVE Life Sciences (WVE) Singapore $0.362B 0.00
Albireo Pharma (ALBO) United States $0.357B 0.00
MannKind (MNKD) United States $0.356B 0.00
Affimed (AFMD) Germany $0.348B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.341B 0.00
Seres Therapeutics (MCRB) United States $0.333B 0.00
PDL BioPharma (PDLI) United States $0.330B 290.00
OSMOTICA PHARM (OSMT) United States $0.321B 0.00
ChromaDex (CDXC) United States $0.318B 0.00
Cellular Biomedicine (CBMG) United States $0.317B 0.00
Prometic Life Sciences (LMNL) Canada $0.299B 0.00
Starpharma Holdings (SPHRY) Australia $0.292B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.288B 0.00
Pfenex (PFNX) United States $0.279B 0.00
Spero Therapeutics (SPRO) United States $0.276B 0.00
Menlo Therapeutics (MNLO) United States $0.272B 0.00
Northwest Biotherapeutics (NWBO) United States $0.251B 0.00
ADMA Biologics Inc (ADMA) United States $0.250B 0.00
NextCure (NXTC) United States $0.248B 0.00
Dyadic (DYAI) United States $0.247B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.246B 0.00
Celldex Therapeutics (CLDX) United States $0.242B 0.00
Abeona Therapeutics (ABEO) United States $0.242B 0.00
Verastem (VSTM) United States $0.232B 0.00
HOOKIPA Pharma (HOOK) United States $0.231B 0.00
IVERIC Bio (ISEE) United States $0.230B 0.00
Aduro Biotech (ADRO) United States $0.229B 0.00
Five Prime Therapeutics (FPRX) United States $0.225B 0.00
Fortress Biotech (FBIO) United States $0.222B 0.00
Selecta Biosciences (SELB) United States $0.221B 0.00
Pluristem Therapeutics (PSTI) Israel $0.220B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.220B 3.32
Exicure (XCUR) United States $0.214B 0.00
Aptinyx (APTX) United States $0.209B 0.00
Sutro Biopharma (STRO) United States $0.207B 0.00
XOMA (XOMA) United States $0.205B 0.00
Strongbridge Biopharma (SBBP) United States $0.204B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.203B 0.00
GENFIT S.A (GNFT) France $0.202B 0.00
Trevena (TRVN) United States $0.198B 0.00
POXEL SA FRANCE (PXXLF) France $0.190B 0.00
Liquidia Technologies (LQDA) United States $0.187B 0.00
ARAVIVE, INC (ARAV) United States $0.179B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.168B 0.00
Theratechnologies (THTX) Canada $0.166B 0.00
Kindred Biosciences (KIN) United States $0.165B 0.00
TELA Bio (TELA) United States $0.162B 0.00
Aytu Bioscience (AYTU) United States $0.159B 0.00
VTv Therapeutics (VTVT) United States $0.159B 0.00
Cidara Therapeutics (CDTX) United States $0.154B 0.00
Cerecor (CERC) United States $0.154B 0.00
VolitionRX (VNRX) United States $0.152B 0.00
CorMedix Inc (CRMD) United States $0.152B 0.00
Applied Genetic Technologies (AGTC) United States $0.149B 0.00
Bellus Health (BLU) Canada $0.148B 0.00
Celyad SA (CYAD) Belgium $0.147B 0.00
Gritstone Oncology (GRTS) United States $0.145B 0.00
Biofrontera AG (BFRA) Germany $0.142B 0.00
PHASEBIO PHARMA (PHAS) United States $0.140B 0.00
Cyclerion Therapeutics (CYCN) United States $0.138B 0.00
Orgenesis (ORGS) United States $0.132B 0.00
Arbutus Biopharma (ABUS) United States $0.130B 0.00
Lumos Pharma (LUMO) United States $0.130B 0.00
Oncobiologics (OTLK) United States $0.126B 0.00
AquaBounty Technologies (AQB) United States $0.124B 0.00
Enzo Biochem (ENZ) United States $0.120B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.119B 0.00
Palatin Technologies (PTN) United States $0.117B 2.99
Lineage Cell Therapeutics (LCTX) United States $0.117B 0.00
Protalix BioTherapeutics (PLX) Israel $0.114B 0.00
Eton Pharmaceuticals (ETON) United States $0.111B 0.00
AIT Therapeutics (XAIR) United States $0.099B 0.00
Cardiff Oncology (CRDF) United States $0.096B 0.00
Windtree Therapeutics (WINT) United States $0.093B 0.00
Emmaus Life Sciences (EMMA) United States $0.091B 0.00
Checkpoint Therapeutics (CKPT) United States $0.091B 0.00
Cocrystal Pharma (COCP) United States $0.091B 0.00
Antibe Therapeutics (ATBPF) Canada $0.090B 0.00
Unum Therapeutics (UMRX) United States $0.090B 0.00
DiaMedica Therapeutics (DMAC) United States $0.089B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.088B 0.00
Vaccinex (VCNX) United States $0.086B 0.00
Organovo Holdings (ONVO) United States $0.084B 0.00
Clearside Biomedical (CLSD) United States $0.084B 0.00
Adocia (ADOCY) France $0.080B 0.00
SESEN BIO, INC (SESN) United States $0.077B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.074B 0.00
Catalyst Biosciences (CBIO) United States $0.070B 0.00
Proteostasis Therapeutics (PTI) United States $0.069B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.068B 0.00
Happiness Biotech Group (HAPP) China $0.067B 0.00
Synlogic (SYBX) United States $0.066B 0.00
Stealth BioTherapeutics (MITO) United States $0.065B 0.00
Idera Pharmaceuticals (IDRA) United States $0.060B 0.00
AnPac Bio-Medical Science (ANPC) China $0.060B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.059B 0.00
Ecology Coatings (ABVC) United States $0.058B 0.00
Soligenix (SNGX) United States $0.057B 0.00
Prima BioMed (IMMP) Australia $0.057B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.056B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.054B 0.00
CollPlant Holdings (CLGN) Israel $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.051B 0.00
Signal Genetics (MGEN) United States $0.049B 0.00
Genetic Technologies (GENE) Australia $0.048B 0.00
Apricus Biosciences (SEEL) United States $0.045B 0.00
Curis (CRIS) United States $0.044B 0.00
Edesa Biotech (EDSA) Canada $0.043B 0.00
Bionano Genomics (BNGO) United States $0.042B 0.00
ATyr Pharma (LIFE) United States $0.042B 0.00
AmpliPhi Biosciences (ARMP) United States $0.041B 0.00
Celsion (CLSN) United States $0.038B 0.00
Acorda Therapeutics (ACOR) United States $0.036B 0.00
Pulmatrix (PULM) United States $0.036B 0.00
Advaxis (ADXS) United States $0.033B 0.00
Cleveland BioLabs (CBLI) United States $0.033B 0.00
OvaScience (MLND) United States $0.032B 0.00
Spherix (AIKI) United States $0.031B 0.00
Chanticleer Holdings (SONN) United States $0.030B 0.00
Cesca Therapeutics (THMO) United States $0.030B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.030B 0.00
IMMURON (IMRN) Australia $0.029B 0.00
Novogen (KZIA) Australia $0.029B 0.00
Alimera Sciences (ALIM) United States $0.028B 0.00
Titan Pharmaceuticals (TTNP) United States $0.027B 0.00
Evogene (EVGN) Israel $0.027B 0.00
BioPharmX (TMBR) United States $0.026B 0.00
Aptevo Therapeutics (APVO) United States $0.025B 0.00
FORTE BIOSCIENC (FBRX) United States $0.024B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.023B 0.00
Prana Biotechnology (ATHE) Australia $0.023B 0.00
Entera Bio (ENTX) Israel $0.022B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.022B 0.00
BioCardia (BCDA) United States $0.016B 0.00
MYOS RENS Technology (MYOS) United States $0.015B 0.00
Neuralstem (SNCA) United States $0.013B 0.00
TRACON Pharmaceuticals (TCON) United States $0.011B 0.00
AEterna Zentaris (AEZS) United States $0.010B 0.00
VIVUS (VVUS) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00